Literature DB >> 9820602

Contribution of HLA class II genes to susceptibility in achalasia.

E G De la Concha1, M Fernandez-Arquero, J L Mendoza, L Conejero, M A Figueredo, J Perez de la Serna, M Diaz-Rubio, A Ruiz de Leon.   

Abstract

Achalasia is a motor disorder of the esophagus resulting in functional obstruction. The cause of the lesion is unknown although genetic and immunologic factors have been suggested. An association with serological HLA epitopes has been previously reported. In this study, we have further examined this HLA class II association with susceptibility to achalasia by DNA based methods. Achalasia patients (n=40) and healthy controls (n=275), all Caucasians and unrelated, were included in the analysis. The strongest associations were with HLA-DQA1*0101 and two HLA-DQ alphabeta heterodimers having their alpha chain encoded by this allele. Moreover, relative risk was significantly higher in DQA1*0101 homozygotes as compared to heterozygotes and results suggested that DQB1*02 may have a protective role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820602     DOI: 10.1111/j.1399-0039.1998.tb03059.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  15 in total

1.  Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia.

Authors:  Giovanni Sarnelli; Michela Grosso; Ilaria Palumbo; Marcella Pesce; Alessandra D'Alessandro; Giovanni Zaninotto; Vito Annese; Raffaella Petruzzelli; Paola Izzo; Rossana Sepulveres; Dario Bruzzese; Giuseppe Esposito; Rosario Cuomo
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

Review 2.  Achalasia: will genetic studies provide insights?

Authors:  Henning R Gockel; Johannes Schumacher; Ines Gockel; Hauke Lang; Thomas Haaf; Markus M Nöthen
Journal:  Hum Genet       Date:  2010-08-11       Impact factor: 4.132

3.  Myenteric antiplexus antibodies and class II HLA in achalasia.

Authors:  Antonio Ruiz-de-León; Juan Mendoza; Concepción Sevilla-Mantilla; Arquero Miguel Fernández; Julio Pérez-de-la-Serna; Vigo Ana Gónzalez; Enrique Rey; Angeles Figueredo; Manuel Díaz-Rubio; Emilio G De-la-Concha
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

Review 4.  Update on the Diagnosis and Treatment of Achalasia.

Authors:  Wojciech Blonski; Samuel Slone; Joel E Richter
Journal:  Dysphagia       Date:  2022-05-18       Impact factor: 3.438

5.  An Overview of Achalasia and Its Subtypes.

Authors:  Dhyanesh A Patel; Brian M Lappas; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

6.  Histopathologic patterns among achalasia subtypes.

Authors:  J B Sodikoff; A A Lo; B B Shetuni; P J Kahrilas; G-Y Yang; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2015-11-06       Impact factor: 3.598

7.  Endoscopic treatment of esophageal achalasia.

Authors:  Dario Esposito; Francesco Maione; Alessandra D'Alessandro; Giovanni Sarnelli; Giovanni D De Palma
Journal:  World J Gastrointest Endosc       Date:  2016-01-25

Review 8.  Pathogenesis of achalasia cardia.

Authors:  Uday C Ghoshal; Sunil B Daschakraborty; Renu Singh
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

9.  Genetic contribution to motility disorders of the upper gastrointestinal tract.

Authors:  Giovanni Sarnelli; Alessandra D'Alessandro; Marcella Pesce; Ilaria Palumbo; Rosario Cuomo
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

Review 10.  Idiopathic (primary) achalasia.

Authors:  Farnoosh Farrokhi; Michael F Vaezi
Journal:  Orphanet J Rare Dis       Date:  2007-09-26       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.